What Have We Learned From Malpractice Claims Involving the Surgical Management of Benign Biliary Disease?: A 128 Million Dollar Question.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 3 1 2019
medline: 9 1 2020
entrez: 3 1 2019
Statut: ppublish

Résumé

We aimed to study the contributing factors and costs of malpractice claims involving the surgical management of benign biliary disease given the emotional, physical, and financial toll of these claims on patients, providers, and the healthcare system. Cholecystectomy complications carry significant morbidity and rank among the leading sources of surgical malpractice claims. Using the CRICO Strategies' Comparative Benchmarking System database, representing approximately 30% of all paid and unpaid malpractice claims in the United States, 4081 closed claims filed against general surgeons from 1995 to 2015 were reviewed to isolate 745 cholecystectomy-related claims. A multivariable model was used to determine factors associated with claim outcome. The most common associated complications included bile duct injury (n = 397), bowel perforation (n = 96), and hemorrhage (n = 78). Bile duct injuries were recognized intraoperatively only 19% of the time and required biliary reconstruction surgery 77% of the time. The total cost for all claims over the study period was over $128 M and the median time from event to case close was over 3 years. 40% of claims resulted in patient payout; of these, most claims were settled out of court and the median cost per claim was $264,650. For the 60% of claims not resulting in patient payout, most cases were denied, dropped, or dismissed, yet still averaged over $15,000 per claim in legal and administrative fees. On multivariable analysis, bile duct injury, bowel perforation, and high clinical severity were associated with patient payout, while a resident or fellow being named in a claim was negatively associated with patient payout (P < 0.05). Cholecystectomy-related claims are costly and time-consuming. Strategies that reduce the risk and aid in recognition of cholecystectomy complications, as well as advance support of patients and families after poor outcomes, may improve clinical care and reduce claim burden.

Sections du résumé

OBJECTIVE
We aimed to study the contributing factors and costs of malpractice claims involving the surgical management of benign biliary disease given the emotional, physical, and financial toll of these claims on patients, providers, and the healthcare system.
SUMMARY BACKGROUND DATA
Cholecystectomy complications carry significant morbidity and rank among the leading sources of surgical malpractice claims.
METHODS
Using the CRICO Strategies' Comparative Benchmarking System database, representing approximately 30% of all paid and unpaid malpractice claims in the United States, 4081 closed claims filed against general surgeons from 1995 to 2015 were reviewed to isolate 745 cholecystectomy-related claims. A multivariable model was used to determine factors associated with claim outcome.
RESULTS
The most common associated complications included bile duct injury (n = 397), bowel perforation (n = 96), and hemorrhage (n = 78). Bile duct injuries were recognized intraoperatively only 19% of the time and required biliary reconstruction surgery 77% of the time. The total cost for all claims over the study period was over $128 M and the median time from event to case close was over 3 years. 40% of claims resulted in patient payout; of these, most claims were settled out of court and the median cost per claim was $264,650. For the 60% of claims not resulting in patient payout, most cases were denied, dropped, or dismissed, yet still averaged over $15,000 per claim in legal and administrative fees. On multivariable analysis, bile duct injury, bowel perforation, and high clinical severity were associated with patient payout, while a resident or fellow being named in a claim was negatively associated with patient payout (P < 0.05).
CONCLUSION
Cholecystectomy-related claims are costly and time-consuming. Strategies that reduce the risk and aid in recognition of cholecystectomy complications, as well as advance support of patients and families after poor outcomes, may improve clinical care and reduce claim burden.

Identifiants

pubmed: 30601246
doi: 10.1097/SLA.0000000000003155
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

785-791

Commentaires et corrections

Type : CommentIn

Auteurs

Rajshri M Gartland (RM)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, MA.

Jordan P Bloom (JP)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Zhi Ven Fong (ZV)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Courtney DeRoo (C)

CRICO Risk Management Foundation, Boston, MA.

Kathy Dwyer (K)

CRICO Risk Management Foundation, Boston, MA.

Gene Quinn (G)

CRICO Risk Management Foundation, Boston, MA.

Keith Lillemoe (K)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Elizabeth Mort (E)

Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, MA.
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH